Figure (Emend 01)
Emend Kit
Product Images NDC 0006-3862
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Emend (NDC 0006-3862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Emend 02)
Figure (Emend 03)
Figure (Emend 04)
Figure (Emend 05)
Figure (Emend 06)
Figure (Emend 07)
Figure (Emend 08)
Figure (Emend 09)
Figure (Emend 10)
Chemical Structure (Emend 11)
Figure 1 (Emend 12)
The text provides results from two studies comparing the EMEND Regimen with standard therapy. The first study included 260 participants on the EMEND Regimen and 261 on standard therapy. The second study included 100 participants on the EMEND Regimen and 263 on standard therapy. There seems to be a graph or table showing results over time (24, 48, 72, 96, and 120) for the two treatment groups, but the quality of the makes it impossible to discern the information contained in it.*
Figure 2 (Emend 13)
This is a table about the effectiveness of a 3 EMEND Regimen compared to a Standard Therapy in two different studies. The table includes the percentage of patients (out of 177 or 158, respectively) who benefitted from each treatment during chemotherapy cycles. There is not enough information to determine what condition or disease is being treated by these regimens.*
Warning (Emend 14)
Figure (Emend 15)
Figure (Emend 16)
Figure (Emend 17)
Figure (Emend 18)
Principal Display Panel (80 mg Capsule Dose Pack)
This is a medication package of EMEND capsules (aprepitant) used to prevent nausea and vomiting before chemotherapy on the Day 1. The BiPack includes 2 capsules of EMEND, one taken on Day 2 and the other taken on Day 3, each capsule contains 80mg of aprepitant. The usual dosage should be checked in the accompanying circular. The medicine should be stored at 20-25°C (63-77°F) and out of the reach of children. The package has an NDC number 0006-0461-02. The rest of the text is not-readable.*
Principal Display Panel (125 mg Capsule Carton)
EMEND® is a medication available in capsule form for adults and pediatric patients over the age of 12. The capsules contain 125mg aprepitant and should be stored at room temperature. Consult the accompanying manual for further dosage instructions. The NDC code for this medication is 0006-0462-06.*
Principal Display Panel (3 Capsule Kit Carton)
Principal Display Panel (40 mg Capsule Carton)
EMEND® is a prescription drug available in a capsule form containing 40mg of aprepitant meant for adult use only. The drug is indicated for treating nausea and vomiting that occurs due to chemotherapy. It is essential to store the medication in a controlled room temperature and keep it out of reach of children. The package is not child-resistant. Further dosage instructions can be obtained from the accompanying circular.*
Principal Display Panel (Kit Carton)
This is a description of a Single-Dose Kit containing Emend medication used for oral administration only. The pouch contains 125 mg aprepitant. The kit includes 1 mixing cup, 2 oral dispensers and a cap. Discard unused portions or store as per packaging instructions. It must be reconstituted before use and the dosage needs to be measured by a specific tool. This drug is RX only and must be kept away from children. However, further instructions are available in the package insert. The NDC code is 0006-3066-03. There is also a pharmacy label included.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
